March 31, 2017 / 9:24 PM / 4 months ago

BRIEF-Mylan provides update on Meridian Medical Technologies', expands voluntary worldwide recall of epipen auto-injector

1 Min Read

March 31 (Reuters) - Mylan Nv:

* Mylan provides update on meridian medical technologies', a Pfizer company, expanded voluntary worldwide recall of epipen® auto-injector

* Mylan - recall is being conducted as result of receipt of 2 previously disclosed reports of failure to activate device due to potential defect in supplier component

* Mylan NV - expanded voluntary recall is being initiated in U.S. And also will extend to additional markets in Europe, Asia, North and South America.

* Mylan NV - recall is being expanded to include additional lots as a precautionary measure

* Mylan NV says recall impacts 0.3 mg and 0.15 mg strengths of epipen auto-injector

* Mylan NV- none of recalled lots include authorized generic for epipen auto-injector, which is also manufactured by meridian medical technologies Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below